Advertisement
Screener

Rain Oncology Inc. Patents: Applications Pending

Rain Oncology Inc. Patent Applications Pending

9 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2020-12-18: Application PCTUS2020066040; Invention METHODS OF INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR PROTEINS; Applicant RAIN THERAPEUTICS INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2020-03-27: Application PCTUS2020025472; Invention USE OF BIOMARKER IN CANCER THERAPY; Applicant RAIN THERAPEUTICS INC.; Status PCT - International Search Report Mailed to IB.
  • 2019-12-19: Application 62950217; Invention METHODS OF INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR PROTEINS; Applicant Rain Therapeutics Inc.; Status Provisional Application Expired.
  • 2019-11-13: Application PCTUS2019061121; Invention COMBINATION OF A KINASE INHIBITOR AND AN ELECTROLYTE, COMPOSITIONS AND METHODS COMPRISING THE SAME; Applicant RAIN THERAPEUTICS INC.; Status PCT - International Search Report Mailed to IB.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2020-12-18PCTUS2020066040METHODS OF INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR PROTEINSRAIN THERAPEUTICS INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
ALLAN S. WAGMAN
United States
2020-03-27PCTUS2020025472USE OF BIOMARKER IN CANCER THERAPYRAIN THERAPEUTICS INC.PCT - International Search Report Mailed to IB
VIJAYA TIRUNAGARU
United States
YOUNG, LEE W
2019-12-1962950217METHODS OF INHIBITING EPIDERMAL GROWTH FACTOR RECEPTOR PROTEINSRain Therapeutics Inc.Provisional Application Expired
Allan S. WAGMAN
United States
2019-11-13PCTUS2019061121COMBINATION OF A KINASE INHIBITOR AND AN ELECTROLYTE, COMPOSITIONS AND METHODS COMPRISING THE SAMERAIN THERAPEUTICS INC.PCT - International Search Report Mailed to IB
JAY MASON
VIJAYA TIRUNAGARU
United States
United States
YOUNG, LEE W
2019-09-04PCTUS2019049507COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HER-DRIVEN CANCERSRAIN THERAPEUTICS INC.PCT - International Search Report Mailed to IB
VIJAYA TIRUNAGARU
AVANISH VELLANKI
United States
United States
THOMAS, SHANE M
2019-03-2962826075COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HER-DRIVEN CANCERSRain Therapeutics Inc.Provisional Application Expired
Avanish VELLANKI
Vijaya TIRUNAGARU
United States
United States
2019-03-2962826062STEAP4 ISH and IHC Diagnostics for Tarloxotinib activation in EGFR/HER2 Mutant CancersRain Therapeutics Inc.Provisional Application Expired
Vijaya TIRUNAGARU
United States
2018-11-1362760325COMBINATION OF A KINASE INHIBITOR AND AN ELECTROLYTE, COMPOSITIONS AND METHODS COMPRISING THE SAMERain Therapeutics Inc.Provisional Application Expired
Vijaya Tirunagaru
Jay Mason
United States
United States
2018-09-0462726946COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING HER-DRIVEN CANCERSRain Therapeutics Inc.Provisional Application Expired
Vijaya Tirunagaru
United States